Vyome Holdings, Inc (HIND) stock
HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.54+0.01 (+0.98%)
Close on Nov 17, 2026Market cap $10.84MP/E –Yield –
Vyome operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Vyome's operating cash flow for the twelve months ending Jun 30, 2026 was -$5.58M, down 342.0% year over year. For fiscal 2025 it was -$3.75M. The highest annual figure on record is -$614.14K in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.75M | – |
| FY2024 | Dec 31, 2024 | -$614.14K | – |
| FY2023 | Dec 31, 2023 | -$16.96M | – |
| FY2022 | Dec 31, 2022 | -$21.90M | – |
| FY2021 | Dec 31, 2021 | -$15.38M | – |
| FY2020 | Dec 31, 2020 | -$8.55M | – |
| FY2019 | Dec 31, 2019 | -$22.87M | – |
| FY2018 | Dec 31, 2018 | -$29.43M | – |
| FY2017 | Dec 31, 2017 | -$30.62M | – |
| FY2016 | Dec 31, 2016 | -$19.37M | – |
| FY2015 | Dec 31, 2015 | -$11.39M | – |
| FY2014 | Dec 31, 2014 | -$9.91M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$903.71K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.44M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.48M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.76M | -162.5% |
| Q2 FY2025 | Jun 30, 2025 | -$306.25K | – |
| Q1 FY2025 | Mar 31, 2025 | -$203.53K | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.97K | – |
| Q3 FY2024 | Sep 30, 2024 | $2.82M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.36M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.07M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.46M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.78M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.66M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.06M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.83M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.27M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.42M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.38M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.43M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.80M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.19M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.96M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.76M | – |
| Q3 FY2020 | Sep 30, 2020 | -$976.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$998.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.81M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.88M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.99M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.36M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.64M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.42M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.29M | – |
| Q2 FY2018 | Jun 30, 2018 | -$8.12M | – |
| Q1 FY2018 | Mar 31, 2018 | -$10.60M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.20M | – |
| Q3 FY2017 | Sep 30, 2017 | -$7.02M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.06M | – |
| Q1 FY2017 | Mar 31, 2017 | -$8.35M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.78M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.93M | – |
See a number that looks wrong?